Managing Adaptive Oncology Trials Within IRB Frameworks

This whitepaper examines how adaptive clinical trial designs in oncology can improve patient outcomes and treatment efficacy through real-time modifications, while also highlighting the regulatory and ethical challenges these designs pose within IRB frameworks.